Global Cord Blood Corp

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Global Cord Blood Corp. operates as a holding company, which engages in providing cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. It provides parents of newborn infants with umbilical cord blood storage services. The company was founded on January 17, 2008 and is headquartered in Hong Kong.

LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Global Cord Blood Corporation ("Global Cord" or "the Company") (OTC PINK:CORBF) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 4, 2019 and May 3, 2022, inclusive (the "Class Period"), are encouraged to contact the firm before June 24, 2024.

IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Global Cord Blood Corporation with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Global Cord Blood Corporation ("Global Cord" or "the Company") (OTC PINK:CORBF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 4, 2019 and May 3, 2022, inclusive (the "Class Period"), are encouraged to contact the firm before June 24, 2024.

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in Global Cord Blood Corporation with Losses to Contact the Firm

NEW YORK , May 16, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Global Cord Blood Corporation ("Global Cord" or the "Company") (OTC: CORBF) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24-cv-03071, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Global Cord securities between June 4, 2019 and May 3, 2022, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines - CORBF

LOS ANGELES , May 15, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Global Cord Blood Corporation ("Global Cord" or the "Company") (OTC: CORBF).

CORBF Investors Have Opportunity to Lead Global Cord Blood Corporation Securities Fraud Lawsuit

Global Cord Blood

NEW YORK , May 13, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the "Class Period"), of the important June 24, 2024 lead plaintiff deadline. SO WHAT: If you purchased Global Cord securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF

Upcoming Lead Plaintiff Deadline is June 21, 2024 NEW YORK , May 10, 2024 /PRNewswire/ --  Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a federal securities class action lawsuit has been filed against Global Cord Blood Corporation ("Global Cord" or the "Company") (OTC: CORBF) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Global Cord securities between June 4, 2019 and May 3, 2022, both dates inclusive (the "Class Period"). A ll investors who purchased shares and incurred losses are advised  to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Global Cord Blood Corporation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming June 24, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) securities between June 4, 2019 and May 3, 2022, inclusive (the “Class Period”). Investors suffering losses on their Global Cord investments are encouraged to contact the Law Offices of Howard G. Smith to discuss the.

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)

NEW YORK , May 6, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the "Class Period"), of the important June 24, 2024 lead plaintiff deadline. SO WHAT: If you purchased Global Cord securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) securities between June 4, 2019 and May 3, 2022, inclusive (the “Class Period”). Global Cord investors have until June 24, 2024 to file a lead plaintiff motion. If you suffered a loss on your.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Global Cord Blood Corporation (CORBF) Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) securities between June 4, 2019 and May 3, 2022, inclusive (the “Class Period”). Global Cord investors have until June 21, 2024 to file a lead plaintiff motion. Investors suffering losses on their Global Cord investments are encouraged to contact the Law Offices of Howa.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Global Cord Blood Corporation (CORBF) Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Global Cord investments or would like to inquire about potentially pursuing claims to recover your loss under the fede.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Global Cord Blood Corporation (CORBF) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) investors concerning the Company's possible violations of federal securities laws. On April 29, 2022, Global Cord announced that it had entered into a Material Definitive Agreement to acquire biotechnology company, Cellenkos Inc. (“Cellenkos”) for over $1 billion, including $664 million in cash and 114 million Global C.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Global Cord Blood Corporation (CORBF) on Behalf of Investors

NEW YORK, April 26, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

ROSEN, A RANKED AND LEADING FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF

News for Global Cord Blood Corp Stock (CORBF)